Market Closed -
Japan Exchange
07:00:00 17/05/2024 BST
|
5-day change
|
1st Jan Change
|
1,712
JPY
|
+0.12%
|
|
-6.04%
|
-3.82%
|
Fiscal Period: März |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
123,794
|
125,915
|
110,478
|
101,826
|
97,646
|
98,352
|
-
|
-
|
Enterprise Value (EV)
1 |
115,308
|
116,590
|
101,516
|
95,956
|
99,529
|
104,097
|
98,352
|
98,352
|
P/E ratio
|
20.6
x
|
20.5
x
|
18
x
|
25.9
x
|
20.7
x
|
19.5
x
|
19.2
x
|
25.6
x
|
Yield
|
3.47%
|
3.41%
|
3.89%
|
2.93%
|
3.05%
|
2.87%
|
3.04%
|
3.04%
|
Capitalization / Revenue
|
1.09
x
|
1.14
x
|
1.07
x
|
0.96
x
|
0.86
x
|
0.87
x
|
0.79
x
|
0.79
x
|
EV / Revenue
|
1.09
x
|
1.14
x
|
1.07
x
|
0.96
x
|
0.86
x
|
0.87
x
|
0.79
x
|
0.79
x
|
EV / EBITDA
|
10.4
x
|
11.7
x
|
11.8
x
|
11.7
x
|
10.9
x
|
8.95
x
|
8.85
x
|
10.4
x
|
EV / FCF
|
-30.4
x
|
25
x
|
119
x
|
26.9
x
|
-22.9
x
|
-37.5
x
|
-
|
-
|
FCF Yield
|
-3.29%
|
3.99%
|
0.84%
|
3.72%
|
-4.37%
|
-2.66%
|
-
|
-
|
Price to Book
|
1
x
|
1.03
x
|
0.89
x
|
0.82
x
|
0.78
x
|
0.8
x
|
0.74
x
|
0.74
x
|
Nbr of stocks (in thousands)
|
57,285
|
57,286
|
57,302
|
57,302
|
57,304
|
57,449
|
-
|
-
|
Reference price
2 |
2,161
|
2,198
|
1,928
|
1,777
|
1,704
|
1,712
|
1,712
|
1,712
|
Announcement Date
|
13/05/19
|
12/05/20
|
11/05/21
|
11/05/22
|
11/05/23
|
10/05/24
|
-
|
-
|
Fiscal Period: März |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
113,620
|
109,983
|
102,904
|
105,534
|
113,270
|
119,532
|
124,600
|
124,600
|
EBITDA
1 |
11,912
|
10,724
|
9,350
|
8,721
|
8,963
|
10,984
|
11,110
|
9,413
|
EBIT
1 |
8,972
|
7,503
|
5,786
|
5,007
|
5,123
|
6,013
|
6,500
|
4,800
|
Operating Margin
|
7.9%
|
6.82%
|
5.62%
|
4.74%
|
4.52%
|
5.03%
|
5.22%
|
3.85%
|
Earnings before Tax (EBT)
1 |
9,359
|
8,255
|
8,352
|
5,216
|
6,906
|
7,019
|
7,030
|
5,330
|
Net income
1 |
6,869
|
6,149
|
6,130
|
3,932
|
4,723
|
5,322
|
5,090
|
3,860
|
Net margin
|
6.05%
|
5.59%
|
5.96%
|
3.73%
|
4.17%
|
4.45%
|
4.09%
|
3.1%
|
EPS
2 |
104.7
|
107.4
|
107.0
|
68.62
|
82.44
|
92.74
|
89.00
|
67.00
|
Free Cash Flow
1 |
-4,078
|
5,030
|
930
|
3,786
|
-4,267
|
-2,620
|
-
|
-
|
FCF margin
|
-3.59%
|
4.57%
|
0.9%
|
3.59%
|
-3.77%
|
-2.18%
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
46.9%
|
9.95%
|
43.41%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
81.8%
|
15.17%
|
96.29%
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
75.00
|
75.00
|
75.00
|
52.00
|
52.00
|
52.00
|
52.00
|
52.00
|
Announcement Date
|
13/05/19
|
12/05/20
|
11/05/21
|
11/05/22
|
11/05/23
|
10/05/24
|
-
|
-
|
Fiscal Period: März |
2020 S1
|
2021 S1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2024 Q1
|
2024 S1
|
2024 Q3
|
---|
Net sales
1 |
48,299
|
47,735
|
49,102
|
28,615
|
24,619
|
49,093
|
31,614
|
27,854
|
54,937
|
32,330
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
783
|
1,502
|
-68
|
2,994
|
489
|
777
|
3,925
|
710
|
1,144
|
3,321
|
Operating Margin
|
1.62%
|
3.15%
|
-0.14%
|
10.46%
|
1.99%
|
1.58%
|
12.42%
|
2.55%
|
2.08%
|
10.27%
|
Earnings before Tax (EBT)
1 |
1,178
|
2,874
|
269
|
3,229
|
1,658
|
1,812
|
4,149
|
913
|
2,349
|
2,801
|
Net income
1 |
834
|
2,118
|
121
|
2,362
|
1,183
|
1,242
|
3,135
|
676
|
1,757
|
2,157
|
Net margin
|
1.73%
|
4.44%
|
0.25%
|
8.25%
|
4.81%
|
2.53%
|
9.92%
|
2.43%
|
3.2%
|
6.67%
|
EPS
2 |
14.56
|
36.98
|
2.120
|
41.22
|
20.65
|
21.69
|
54.71
|
11.81
|
30.66
|
37.57
|
Dividend per Share
|
30.00
|
30.00
|
20.00
|
-
|
-
|
20.00
|
-
|
-
|
20.00
|
-
|
Announcement Date
|
07/11/19
|
05/11/20
|
08/11/21
|
04/02/22
|
02/08/22
|
09/11/22
|
06/02/23
|
02/08/23
|
08/11/23
|
06/02/24
|
Fiscal Period: März |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
1,883
|
-
|
-
|
-
|
Net Cash position
|
8,486
|
9,325
|
8,962
|
5,870
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
0.2101
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
-4,078
|
5,030
|
930
|
3,786
|
-4,267
|
-2,620
|
-
|
-
|
ROE (net income / shareholders' equity)
|
4.8%
|
5%
|
5%
|
3.2%
|
3.8%
|
4.2%
|
3.9%
|
2.9%
|
ROA (Net income/ Total Assets)
|
5.08%
|
4.75%
|
3.81%
|
3.29%
|
3.35%
|
3.73%
|
2.8%
|
2.1%
|
Assets
1 |
135,147
|
129,446
|
160,826
|
119,693
|
141,021
|
142,572
|
181,786
|
183,810
|
Book Value Per Share
2 |
2,154
|
2,142
|
2,176
|
2,173
|
2,189
|
2,277
|
2,313
|
2,328
|
Cash Flow per Share
2 |
149.0
|
164.0
|
169.0
|
133.0
|
149.0
|
167.0
|
167.0
|
146.0
|
Capex
1 |
4,418
|
2,709
|
4,259
|
2,560
|
5,252
|
6,000
|
6,000
|
2,000
|
Capex / Sales
|
3.89%
|
2.46%
|
4.14%
|
2.43%
|
4.64%
|
5%
|
4.82%
|
1.61%
|
Announcement Date
|
13/05/19
|
12/05/20
|
11/05/21
|
11/05/22
|
11/05/23
|
10/05/24
|
-
|
-
|
Mean consensus UNDERPERFORM Last Close Price
1,712
JPY Average target price
1,300
JPY Spread / Average Target -24.07% Consensus |
1st Jan change
|
Capi.
|
---|
| -3.82% | 633M | | +32.09% | 694B | | +29.39% | 593B | | -1.34% | 371B | | +20.34% | 331B | | +7.39% | 290B | | +14.25% | 239B | | -3.03% | 209B | | +10.02% | 209B | | +8.49% | 169B |
Other Pharmaceuticals
|